Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Lafex ER Venlafaxine Hydrochloride Tablets BP
Lafex ER Venlafaxine Hydrochloride Tablets BP, developed by Lexaro Healthcare, provides a controlled-release delivery of Venlafaxine Hydrochloride, ensuring a steady therapeutic effect over time. This formulation is designed to enhance patient compliance by reducing the frequency of dosing while effectively managing symptoms of depression and anxiety.
Uses of Lafex ER Venlafaxine Hydrochloride Tablets BP
Lafex ER is primarily used for:
Treating major depressive disorder (MDD).
Managing generalized anxiety disorder (GAD).
Alleviating symptoms of social anxiety disorder (SAD).
Providing relief from anxiety and mood-related symptoms.
Benefits of Lafex ER Venlafaxine Hydrochloride Tablets BP
Extended Release: Provides a consistent release of Venlafaxine, maintaining stable blood levels and reducing the need for frequent dosing.
Effective Management of Depression: Helps improve mood and alleviate symptoms of major depressive disorder.
Anxiety Reduction: Effective in managing symptoms of generalized anxiety disorder and social anxiety disorder.
Improved Quality of Life: Enhances overall quality of life by reducing anxiety and depression-related symptoms.
Well-Tolerated: Generally well-tolerated with a favorable side effect profile.
Mechanism of Action of Lafex ER Venlafaxine Hydrochloride Tablets BP
Venlafaxine Hydrochloride works by:
Inhibiting Reuptake of Neurotransmitters: Venlafaxine increases the levels of serotonin and norepinephrine in the brain by inhibiting their reuptake. This action helps to improve mood and alleviate symptoms of depression and anxiety.
Balanced Neurotransmitter Activity: By affecting both serotonin and norepinephrine levels, Venlafaxine provides a balanced approach to managing mood and anxiety disorders.
Extended-Release Mechanism: The extended-release formulation allows for a gradual release of the medication, ensuring stable plasma levels and minimizing peaks and troughs that can affect efficacy and tolerability.